Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Feb;47(2):217–228. doi: 10.1111/j.1476-5381.1973.tb08319.x

Further evidence for a central hypotensive action of α-methyldopa in both the rat and cat

L Finch, G Haeusler
PMCID: PMC1776563  PMID: 4722038

Abstract

1. α-Methyldopa (300 mg/kg i.p.) produced a fall in blood pressure in conscious genetic hypertensive rats. Pretreatment with intraventricular 6-hydroxydopamine prevented this hypotensive effect of α-methyldopa, whilst intravenous 6-hydroxydopamine reduced but did not prevent the hypotension.

2. The hypotensive effect of α-methyldopa was prevented or reversed by intraventricular injection of phentolamine (200 μg/rat).

3. Pressor responses obtained by stimulation of the entire sympathetic outflow in the Gillespie & Muir preparation, were unaffected by pretreatment with α-methyldopa (300 mg/kg i.p.).

4. Vasoconstrictor responses to periarterial nerve stimulation of the isolated renal artery preparation of the rat were markedly reduced by pretreatment with α-methyldopa. Furthermore, α-methylnoradrenaline was found to have one-eighth the vasoconstrictor potency of noradrenaline in this particular artery preparation.

5. Pressor responses obtained by stimulation of the posterior hypothalamus or midbrain reticular formation in the rat anaesthetized with urethane were markedly reduced by pretreatment with α-methyldopa. FLA-63, a selective dopamine-β-hydroxylase inhibitor, prevented the reduction of the pressor responses to hypothalamic stimulation produced by α-methyldopa.

6. Stimulation of the posterior hypothalamus in the anaesthetized cat caused both an increase in sympathetic nerve activity and a rise in blood pressure. These responses were markedly reduced 3-4 h after the injection of α-methyldopa (100 mg/kg i.v.).

7. These results strongly suggest that the central actions of α-methyldopa are important for its hypotensive effect, although a possible peripheral effect cannot be excluded.

Full text

PDF
217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andén N. E., Fuxe K. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord. Br J Pharmacol. 1971 Dec;43(4):747–756. doi: 10.1111/j.1476-5381.1971.tb07210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ayitey-Smith E., Varma D. R. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats. Br J Pharmacol. 1970 Oct;40(2):186–193. doi: 10.1111/j.1476-5381.1970.tb09912.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baum T., Shropshire A. T. Stimulation of central cardiovascular centers in hypertension. Arch Int Pharmacodyn Ther. 1969 Oct;181(2):405–413. [PubMed] [Google Scholar]
  4. Berkowitz B. A., Spector S., Tarver J. H. Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy. Br J Pharmacol. 1972 Jan;44(1):10–16. doi: 10.1111/j.1476-5381.1972.tb07233.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brezenoff H. E., Jenden D. J. Modification of arterial blood pressure in rats following microinjection of drugs into the posterior hypothalamus. Int J Neuropharmacol. 1969 Dec;8(6):593–600. doi: 10.1016/0028-3908(69)90076-8. [DOI] [PubMed] [Google Scholar]
  6. DAVIS R. A., DRAIN D. J., HORLINGTON M., LAZARE R., URBANSKA A. The effect of L-alpha-methyl DOPA and N-2-hydroxybenzyl-N-methyl hydrazine (NSD 1039) on the blood pressure of renal hypertensive rates. Life Sci. 1963 Mar;3:193–197. doi: 10.1016/0024-3205(63)90050-x. [DOI] [PubMed] [Google Scholar]
  7. DAY M. D., RAND M. J. A hypothesis for the mode of action of alpha-methyldopa in relieving hypertension. J Pharm Pharmacol. 1963 Apr;15:221–224. doi: 10.1111/j.2042-7158.1963.tb12778.x. [DOI] [PubMed] [Google Scholar]
  8. DAY M. D., RAND M. J. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA. Br J Pharmacol Chemother. 1964 Feb;22:72–86. doi: 10.1111/j.1476-5381.1964.tb01545.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Finch L., Haeusler G., Kuhn H., Thoenen H. Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine. Br J Pharmacol. 1972 Feb;44(2):357P–358P. [PMC free article] [PubMed] [Google Scholar]
  10. Finch L., Leach G. D. A comparison of the effects of 6-hydroxydopamine immunosympathectomy and reserpine on the cardiovascular reactivity in the rat. J Pharm Pharmacol. 1970 May;22(5):354–360. doi: 10.1111/j.2042-7158.1970.tb08537.x. [DOI] [PubMed] [Google Scholar]
  11. Finch L. The neurogenic component in the experimental hypertensive rat. Pharmacology. 1971;5(4):245–254. doi: 10.1159/000136196. [DOI] [PubMed] [Google Scholar]
  12. Gagnon D. J., Melville K. I. Alteration of centrally mediated cardiovascular manifestations by intraventricular pronethalol and phentolamine. Int J Neuropharmacol. 1969 Dec;8(6):587–592. doi: 10.1016/0028-3908(69)90075-6. [DOI] [PubMed] [Google Scholar]
  13. Gerold M., Tschirky H. Measurement of blood pressure in unanaesthetized rats and mice. Arzneimittelforschung. 1968 Oct;18(10):1285–1287. [PubMed] [Google Scholar]
  14. Gillespie J. S., Muir T. C. A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br J Pharmacol Chemother. 1967 May;30(1):78–87. doi: 10.1111/j.1476-5381.1967.tb02114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haefely W., Hürlimann A., Thoenen H. Adrenergic transmitter changes and response to sympathetic nerve stimulation after differing pretreatment with alpha-methyldopa. Br J Pharmacol Chemother. 1967 Sep;31(1):105–119. doi: 10.1111/j.1476-5381.1967.tb01981.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hayden J. F., Johnson L. R., Maickel R. P. Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain. Life Sci. 1966 Aug;5(16):1509–1515. doi: 10.1016/0024-3205(66)90227-x. [DOI] [PubMed] [Google Scholar]
  17. Heise A., Kroneberg G. -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa. Eur J Pharmacol. 1972 Feb;17(2):315–317. doi: 10.1016/0014-2999(72)90180-x. [DOI] [PubMed] [Google Scholar]
  18. Henning M. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats. Acta Pharmacol Toxicol (Copenh) 1969;27(2):135–148. doi: 10.1111/j.1600-0773.1969.tb00501.x. [DOI] [PubMed] [Google Scholar]
  19. Henning M., Rubenson A. Evidence for a centrally mediated hypotensive effect of L-dopa in the rat. J Pharm Pharmacol. 1970 Mar;22(3):241–243. doi: 10.1111/j.2042-7158.1970.tb08510.x. [DOI] [PubMed] [Google Scholar]
  20. Henning M., Svensson L. Adrenergic nerve function in the anaesthetized rat after treatment with a-methyldopa. Acta Pharmacol Toxicol (Copenh) 1968;26(5):425–436. doi: 10.1111/j.1600-0773.1968.tb00461.x. [DOI] [PubMed] [Google Scholar]
  21. Henning M., van Zwieten P. A. Central hypotensive effect of alpha-methyldopa. J Pharm Pharmacol. 1968 Jun;20(6):409–417. doi: 10.1111/j.2042-7158.1968.tb09776.x. [DOI] [PubMed] [Google Scholar]
  22. Ingenito A. J., Barrett J. P., Procita L. A centrally mediated peripheral hypotensive effect of alpha-methyldopa. J Pharmacol Exp Ther. 1970 Dec;175(3):593–599. [PubMed] [Google Scholar]
  23. Kobinger W. Uber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;258(1):48–58. [PubMed] [Google Scholar]
  24. MUSCHOLL E., MAITRE L. RELEASE BY SYMPATHETIC STIMULATION OF ALPHA-METHYLNORADRENALINE STORED IN THE HEART AFTER ADMINISTRATION OF ALPHA-METHYLDOPA. Experientia. 1963 Dec 15;19:658–659. doi: 10.1007/BF02151307. [DOI] [PubMed] [Google Scholar]
  25. Malik K. U., Muscholl E. The effect of alpha-methyldopa on the vasoconstrictor responses of the rat mesenteric artery preparation to nerve stimulation. Arzneimittelforschung. 1969 Jul;19(7):1111–1113. [PubMed] [Google Scholar]
  26. Morpurgo C. Pharmacological modifications of sympathetic responses elicited by hypothalamic stimulation in the rat. Br J Pharmacol. 1968 Nov;34(3):532–542. doi: 10.1111/j.1476-5381.1968.tb08482.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. OKAMOTO K., AOKI K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1963 Mar;27:282–293. doi: 10.1253/jcj.27.282. [DOI] [PubMed] [Google Scholar]
  28. Osborne M. W., Wenger J. J., Willems W. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects. J Pharmacol Exp Ther. 1971 Sep;178(3):517–528. [PubMed] [Google Scholar]
  29. POPOVIC V., POPOVIC P. Permanent cannulation of aorta and vena cava in rats and ground squirrels. J Appl Physiol. 1960 Jul;15:727–728. doi: 10.1152/jappl.1960.15.4.727. [DOI] [PubMed] [Google Scholar]
  30. Philippu A., Przuntek H., Heyd G., Burger A. Central effects of sympathomimetic amines on the blood pressure. Eur J Pharmacol. 1971 Jul;15(2):200–208. doi: 10.1016/0014-2999(71)90174-9. [DOI] [PubMed] [Google Scholar]
  31. SHARE N. N., MELVILLE K. I. Centrally mediated sympathetic cardiovascular responses induced by intraventricular norepinephrine. J Pharmacol Exp Ther. 1963 Jul;141:15–21. [PubMed] [Google Scholar]
  32. Salmon G. K., Ireson J. D. A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function. Arch Int Pharmacodyn Ther. 1970 Jan;183(1):60–64. [PubMed] [Google Scholar]
  33. Schmitt H., Schmitt H. Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur J Pharmacol. 1969 Apr;6(1):8–12. doi: 10.1016/0014-2999(69)90057-0. [DOI] [PubMed] [Google Scholar]
  34. Thoenen H., Tranzer J. P. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;261(3):271–288. doi: 10.1007/BF00536990. [DOI] [PubMed] [Google Scholar]
  35. Trinker F. R. The significance of the relative potencies of norepinephrine and alpha-methylnoradrenaline for the mode of action of alpha-methyldopa. J Pharm Pharmacol. 1971 Apr;23(4):306–308. doi: 10.1111/j.2042-7158.1971.tb08665.x. [DOI] [PubMed] [Google Scholar]
  36. Uretsky N. J., Iversen L. L. Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem. 1970 Feb;17(2):269–278. doi: 10.1111/j.1471-4159.1970.tb02210.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES